MedPath

Effect of Synbiotic on reducing insulin resistance in overweight or obese childre

Phase 3
Recruiting
Conditions
Obesity.
Overweight and obesity
Registration Number
IRCT20211226053529N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Age range between 4 -18 years
Obese or overweight children: Obese children, children with a BMI of more than 95% and overweight children, children with a BMI between 85-95%
Children with insulin resistance (HOMA-IR : > 2.5 = Positive for IR)

Exclusion Criteria

Children who developed obesity following synromic disorder or endocrine disorders
Physical disability
Taking corticosteroids
Treated with metformin
Under special treatment or diet
Acute pancreatitis
History of allergies

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin Resistance level. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: HOMA-IR.Index (µU/ml).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath